drugset / Trial / NCT00424931

A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy

NCT00424931

Phase 2 Completed 16 enrolled Alza Corporation
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and effectiveness of JNJ-17216498 compared to modafinil and placebo in patients with narcolepsy, with and without cataplexy.

Timeline

Start
2007-01
Primary completion
2007-11
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-17216498 Unknown 10 mg Oral
Subject JNJ-17216498 Unknown 50 mg Oral
Comparator Modafinil Small molecule 400 mg Oral

Indications